Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063010) titled 'Nationwide Anaphylaxis Registry in Japan' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - National Hospital Organization Sagamihara National Hospital
Condition:
Condition - Allergy and Anaphylaxis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to characterize the triggers, treatment, and management of anaphylaxis in Japan.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who develop anaphylaxis during the study period and meet either of the following criteria: (1) patients who develop anaphylaxis at a participating institution; or (2) patients who visit a participating institution for an emergency or unscheduled visit because of anaphylaxis. No restrictions are placed on age or sex.
Key exclusion criteria - (1) Anaphylaxis occurring as a result of oral food challenges, other provocation tests, or immunotherapy performed in a medical institution. (2) Patients considered inappropriate for inclusion in the study by the attending physician.
Target Size - 1000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 21 Day
Date of IRB - 2026 Year 07 Month 21 Day
Anticipated trial start date - 2027 Year 01 Month 01 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072137
Disclaimer: Curated by HT Syndication.
